ABVC BioPharma, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $681.5K | $248.4K | $60.2K | $85.3K | $5.8M | $4.3M | $144.3K | $226.7K |
| Accounts Receivable | — | — | $1.5K | $98.3K | $280.7K | $159.7K | — | — |
| Inventory | — | — | — | — | $26.0K | — | — | $1.3K |
| Total Current Assets | $2.5M | $2.2M | $1.7M | $3.0M | $7.7M | $6.2M | $878.2K | $566.5K |
| Property, Plant & Equipment | $12.8M | $511.1K | $569.3K | $574.0K | $525.9K | $514.8K | $520.9K | $510.1K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $21.1M | $7.5M | $7.8M | $9.6M | $13.7M | $11.6M | $6.9M | $5.9M |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | $23.0K | $24.0K | — |
| Total Current Liabilities | $6.2M | $6.6M | $6.1M | $5.5M | $3.7M | $4.8M | $6.8M | $11.0M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $7.8M | $6.8M | $6.5M | $6.3M | $4.8M | $8.9M | $7.1M | $11.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-76.9M | $-68.9M | $-64.0M | $-54.9M | $-38.5M | $-25.6M | $-15.9M | $-12.2M |
| Total Stockholders' Equity | $11.1M | $1.2M | $1.6M | $3.1M | $8.8M | $3.4M | $-151.0K | $-5.7M |